Interleukin-6 deficiency enhances atherosclerotic plaque formation and plaque destabilisation in experimental atherosclerosis

被引：0
|
作者：
Selle, T
Bley, S
Tietge, UJ
Winkler, K
Hilfiker, A
Drexler, H
Schieffer, B
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Humboldt Univ, Charite, Berlin, Germany
[3] Univ Hosp Freiburg, Freiburg, Germany
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
303
引用
下载
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [41] Association of interleukin-6 (IL-6) haplotypes with plaque-induced gingivitis in children
    Holla, Lydie Izakovicova
    Musilova, Kristina
    Vokurka, Jan
    Klapusova, Lucie
    Pantuckova, Pavla
    Kukletova, Martina
    Kukla, Lubomir
    Znojil, Vladimir
    ACTA ODONTOLOGICA SCANDINAVICA, 2008, 66 (02) : 105 - 112
  • [42] Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability
    Stein, S.
    Weber, J.
    Nusser-Stein, S.
    Pahla, J.
    Zhang, H.
    Oppi, S.
    Staels, B.
    Gorrell, M. D.
    Luscher, T. F.
    Matter, C. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 322 - 322
  • [43] Copper concentration in serum and atherosclerotic plaque in patients with carotid atherosclerosis
    Tasic, N.
    Radak, D. J.
    Djordjevic-Denic, G.
    Tasic, D.
    Djarmati, D.
    Gajin, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 75 - 75
  • [44] Iron concentrations in atherosclerotic plaque and serum in patients with carotid atherosclerosis
    Tasic, N. M.
    Tasic, D.
    Veselinovic, M.
    Jakovljevic, V.
    Djuric, D.
    Radak, D.
    ACTA PHYSIOLOGICA HUNGARICA, 2015, 102 (02) : 143 - 150
  • [45] Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
    Donners, Marjo M. P. C.
    Wolfs, Ine M. J.
    Stoger, Lauran J.
    van der Vorst, Emiel P. C.
    Pottgens, Chantal C. H.
    Heymans, Stephane
    Schroen, Blanche
    Gijbels, Marion J. J.
    de Winther, Menno P. J.
    PLOS ONE, 2012, 7 (04):
  • [46] ANTI-INFLAMMATORY AGENTS IN EXPERIMENTAL ATHEROSCLEROSIS .2. FAILURE OF ANTIHYPERTENSIVE DRUGS TO EXACERBATE ATHEROSCLEROTIC PLAQUE-FORMATION
    BAILEY, JM
    RANDAZZO, R
    ATHEROSCLEROSIS, 1977, 26 (01) : 91 - 95
  • [47] Expression of HMG-CoA reductase in human coronary atherosclerotic plaques and relationship to plaque destabilisation
    Lee, Cheol Whan
    Park, Chan-Sik
    Hwang, Ilseon
    Kim, Youngji
    Park, Duk-Woo
    Kang, Soo-Jin
    Lee, Seung-Hwan
    Kim, Young-Hak
    Park, Seong-Wook
    Park, Seung-Jung
    HEART, 2011, 97 (09) : 715 - 720
  • [48] Vascular endothelial growth factor enhances atherosclerotic plaque progression
    Celletti, FL
    Waugh, JM
    Amabile, PG
    Brendolan, A
    Hilfiker, PR
    Dake, MD
    NATURE MEDICINE, 2001, 7 (04) : 425 - 429
  • [49] PATHOLOGY OF ATHEROSCLEROSIS, PLAQUE DISRUPTION, AND THROMBUS FORMATION
    DAVIES, MJ
    CURRENT OPINION IN CARDIOLOGY, 1989, 4 (04) : 464 - 467
  • [50] Vascular endothelial growth factor enhances atherosclerotic plaque progression
    Francesca L. Celletti
    Jacob M. Waugh
    Philippe G. Amabile
    Andrea Brendolan
    Paul R. Hilfiker
    Michael D. Dake
    Nature Medicine, 2001, 7 : 425 - 429
12345